Recruitment of patients to the phase II study (COMB study) is ongoing at the clinical study site in Gothenburg and in Stockholm. The study team is sharing information about the study including contact information to the clinical team in Gothenburg and in Stockholm via i.e radio and newspapers during a few weeks in January-February. See link below.

The COMB study,  a clinical phase II, randomized controlled trial,  plan to include 380 patients with moderate to severe Alcohol Use Disorder (AUD). The multicenter study, was initiated in March 2019 and is led by principal investigator Prof. Bo Söderpalm, Sahlgrenska University Hospital, Gothenburg.

https://www.smwg.se/sahlgrenska-forskningsstudie-gbg
https://www.smwg.se/sahlgrenska-forskningsstudie-sthlm